Home
Live Updates
Optimi Health Completes First Production of Novel MDMA Drug Candidate OPTI-MHCL : vimarsana.com
Optimi Health Completes First Production of Novel MDMA Drug Candidate OPTI-MHCL
The Company is producing OPTI-MHCL in-house under its Health Canada issued Dealers Licence using Optimi's scalable, proprietary production method.
Related Keywords
Australia ,
United States ,
United Kingdom ,
Canada ,
Vancouver ,
British Columbia ,
Australian ,
America ,
British ,
Canadian ,
Michael Kydd ,
Justin Kirkland ,
Company Controlled Substances Dealer Licence ,
Health Canada Special Access Program ,
Journey Centers ,
Optimi Health ,
Australian Therapeutic Goods Administration ,
Prescriber Scheme Under Australia Therapeutic Goods Administration ,
Health Canada ,
Optimi Health Corp ,
Dealers Licence ,
Authorized Prescriber Scheme ,
Therapeutic Goods Administration ,
Special Access Program ,
Authorized Prescriber ,
Chief Science Officer ,
Controlled Substances Dealer ,
Investor Relations ,
Dma ,
Drug Candidate ,
Pti Mhcl ,
Ealth Press Release ,
vimarsana.com © 2020. All Rights Reserved.